IL161223A0 - Novel bacterial poultry disease and vaccine therefor - Google Patents

Novel bacterial poultry disease and vaccine therefor

Info

Publication number
IL161223A0
IL161223A0 IL16122302A IL16122302A IL161223A0 IL 161223 A0 IL161223 A0 IL 161223A0 IL 16122302 A IL16122302 A IL 16122302A IL 16122302 A IL16122302 A IL 16122302A IL 161223 A0 IL161223 A0 IL 161223A0
Authority
IL
Israel
Prior art keywords
novel bacterial
poultry disease
vaccine
therefor
bacterial poultry
Prior art date
Application number
IL16122302A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of IL161223A0 publication Critical patent/IL161223A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
IL16122302A 2001-10-26 2002-10-24 Novel bacterial poultry disease and vaccine therefor IL161223A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10152307A DE10152307A1 (de) 2001-10-26 2001-10-26 Neue bakterielle Geflügelkrankheit
PCT/EP2002/011899 WO2003037367A2 (en) 2001-10-26 2002-10-24 New bacterium causing poultry disease and vaccine derived thereof

Publications (1)

Publication Number Publication Date
IL161223A0 true IL161223A0 (en) 2004-09-27

Family

ID=7703460

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16122302A IL161223A0 (en) 2001-10-26 2002-10-24 Novel bacterial poultry disease and vaccine therefor

Country Status (32)

Country Link
US (3) US7794735B2 (xx)
EP (2) EP1942181A1 (xx)
JP (2) JP4447319B2 (xx)
KR (2) KR100954175B1 (xx)
CN (1) CN100471945C (xx)
AR (3) AR037020A1 (xx)
AT (1) ATE391767T1 (xx)
AU (1) AU2002363173B2 (xx)
BR (1) BR0213538A (xx)
CA (1) CA2462652A1 (xx)
CO (1) CO5580796A2 (xx)
CY (1) CY1108178T1 (xx)
DE (2) DE10152307A1 (xx)
DK (1) DK1442114T3 (xx)
EC (1) ECSP045083A (xx)
ES (1) ES2304466T3 (xx)
HK (1) HK1073862A1 (xx)
HR (1) HRP20040366B1 (xx)
HU (1) HU228692B1 (xx)
IL (1) IL161223A0 (xx)
MA (1) MA26293A1 (xx)
MX (1) MXPA04003941A (xx)
MY (1) MY138203A (xx)
NO (1) NO333635B1 (xx)
NZ (1) NZ532805A (xx)
PL (1) PL206589B1 (xx)
PT (1) PT1442114E (xx)
RU (4) RU2456343C2 (xx)
SI (1) SI1442114T1 (xx)
UA (2) UA96948C2 (xx)
WO (1) WO2003037367A2 (xx)
ZA (1) ZA200402499B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10152307A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
RU2012118977A (ru) * 2009-10-09 2013-11-20 Кобенхавнс Университет (Юниверсити Оф Копенгаген) Цитолитический rtx-токсин gallibacterium anatis
CN102406936A (zh) * 2011-11-22 2012-04-11 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗佐剂
CN102380092A (zh) * 2011-11-22 2012-03-21 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗
AU2014234452B2 (en) 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
RU2563885C1 (ru) * 2014-06-03 2015-09-27 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ определения антител к бактериальным антигенам
CN104491856A (zh) * 2014-12-07 2015-04-08 青岛易邦生物工程有限公司 一种禽肺病毒病灭活疫苗的生产方法
CN108728558A (zh) * 2018-05-31 2018-11-02 广西壮族自治区兽医研究所 一种快速检测溶血性曼氏杆菌的pcr扩增引物及其应用
CN111621450B (zh) * 2020-07-10 2022-07-05 青岛易邦生物工程有限公司 一种鸭源鸡杆菌及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855894A (en) 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
JP3992727B2 (ja) * 1992-10-14 2007-10-17 インターベツト・インターナシヨナル・ベー・ベー 家禽病を発症させる新規バクテリアとそれから誘導されたワクチン
US5587305A (en) * 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
RU94023126A (ru) * 1994-06-16 1997-04-10 Всероссийский научно-исследовательский институт экспериментальной ветеринарии им.Я.Р.Коваленко Вакцина против пастереллеза свиней
RU2103355C1 (ru) * 1995-11-23 1998-01-27 Государственное Федеральное предприятие Государственный научный центр прикладной микробиологии Способ получения аттенуированных иммуногенных штаммов pasteurella multocida
FR2760640B1 (fr) * 1997-03-17 1999-05-28 Vetoquinol Sa Utilisation d'une souche de pasteurella haemolytica serotype a6 pour la preparation d'un vaccin contre la pasteurellose bovine due a pasteurella haemolytica
US7304151B2 (en) * 1999-12-17 2007-12-04 University Of Guelph Modified leukotoxin gene and protein
US7521060B2 (en) 2001-10-26 2009-04-21 Boehringer Ingelheim Vetmedica S.A. De C.V. Pathogen for bacterial poultry disease
DE10152307A1 (de) 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit

Also Published As

Publication number Publication date
AU2002363173B2 (en) 2007-09-20
AR067732A2 (es) 2009-10-21
JP5087604B2 (ja) 2012-12-05
US20100104594A1 (en) 2010-04-29
HUP0402098A2 (hu) 2005-02-28
JP2010051324A (ja) 2010-03-11
DE60226057T2 (de) 2009-05-14
HK1073862A1 (en) 2005-10-21
RU2007129099A (ru) 2009-02-10
CA2462652A1 (en) 2003-05-08
HRP20040366B1 (en) 2012-05-31
DE10152307A1 (de) 2003-05-08
US7794735B2 (en) 2010-09-14
WO2003037367A3 (en) 2003-10-09
MY138203A (en) 2009-05-29
CO5580796A2 (es) 2005-11-30
ATE391767T1 (de) 2008-04-15
KR101024887B1 (ko) 2011-03-31
EP1442114A2 (en) 2004-08-04
UA89607C2 (ru) 2010-02-25
US20090181055A1 (en) 2009-07-16
RU2007148219A (ru) 2009-07-10
RU2004116134A (ru) 2005-05-10
ES2304466T3 (es) 2008-10-16
NO333635B1 (no) 2013-07-29
AR037020A1 (es) 2004-10-20
CN1575334A (zh) 2005-02-02
CY1108178T1 (el) 2014-02-12
HRP20040366A2 (en) 2005-04-30
KR20090083941A (ko) 2009-08-04
EP1942181A1 (en) 2008-07-09
PL206589B1 (pl) 2010-08-31
ECSP045083A (es) 2004-08-27
EP1442114B1 (en) 2008-04-09
DE60226057D1 (de) 2008-05-21
ZA200402499B (en) 2005-06-08
PL369963A1 (en) 2005-05-02
SI1442114T1 (sl) 2008-08-31
KR100954175B1 (ko) 2010-04-20
AR073482A2 (es) 2010-11-10
RU2481393C2 (ru) 2013-05-10
MXPA04003941A (es) 2004-11-29
BR0213538A (pt) 2004-10-19
PT1442114E (pt) 2008-05-20
US20110212132A1 (en) 2011-09-01
MA26293A1 (fr) 2004-09-01
HUP0402098A3 (en) 2005-07-28
US7964197B2 (en) 2011-06-21
RU2008136404A (ru) 2010-03-20
NZ532805A (en) 2008-04-30
HU228692B1 (en) 2013-05-28
DK1442114T3 (da) 2008-06-09
RU2430967C2 (ru) 2011-10-10
JP2005511032A (ja) 2005-04-28
RU2334792C2 (ru) 2008-09-27
KR20050039688A (ko) 2005-04-29
CN100471945C (zh) 2009-03-25
NO20041675L (no) 2004-04-23
UA96948C2 (ru) 2011-12-26
WO2003037367A2 (en) 2003-05-08
RU2456343C2 (ru) 2012-07-20
JP4447319B2 (ja) 2010-04-07

Similar Documents

Publication Publication Date Title
IL158107A0 (en) Human papillomaviruses vaccine
GB0130215D0 (en) Vaccine
GB0407935D0 (en) Vaccine
HK1073862A1 (en) New bacterium causing poultry disease and vaccine derived thereof
EP1421185A4 (en) FAST TIE TEMPERATURE PRESSURE STERILIZATION AND VACCINE MANUFACTURING
GB0306611D0 (en) Novel vaccine
HUP0303372A3 (en) Vaccine
EP1423141A4 (en) VACCINE
GB0218205D0 (en) Human ZZAP1 protein
GB0128628D0 (en) Disease treatment
EP1426443A4 (en) NEW HUMAN GENE BMCC1
GB0104168D0 (en) Disease model
GB0126988D0 (en) Disease model
GB0027644D0 (en) Fish vaccine
AU2002351941A1 (en) Fowl adenovirus vaccine
GB0030765D0 (en) Fish vaccine
GB0129338D0 (en) Vaccination
PL374051A1 (en) Salmonella vaccine
GB0107511D0 (en) Novel vaccine
GB0104538D0 (en) Novel Vaccine
GB0104542D0 (en) Novel vaccine
GB0103867D0 (en) Vaccine
GB0128312D0 (en) Vaccine
GB0115496D0 (en) Vaccine
GB0106589D0 (en) Vaccine